They found the switch that makes the body attack cancer-Click HereThis common liver supplement could boost cancer treatment success-Click HereThis European treatment for joint pain just passed a major scientific test-Click HereTiny brain nanotubes found by Johns Hopkins may spread Alzheimer’s-Click HereExercise might be the key to a younger, sharper immune system-Click HereScientists grow mini human livers that predict toxic drug reactions-Click HereThis new blood test can catch cancer 10 years early-Click HereYour brain’s power supply may hold the key to mental illness-Click HereNew research reveals how ADHD sparks extraordinary creativity-Click HereThis experimental “super vaccine” stopped cancer cold in the lab-Click HereSports concussions increase injury risk-Click HereUncovering a cellular process that leads to inflammation-Click HereNew study links contraceptive pills and depression-Click HereA short snout predisposes dogs to sleep apnea-Click HereBuilding a new vaccine arsenal to eradicate polio-Click HereThe Viking disease can be due to gene variants inherited from Neanderthals-Click HereQatar Omicron-wave study shows slow decline of natural immunity, rapid decline of vaccine immunity-Click HereMore than a quarter of people with asthma still over-using rescue inhalers, putting them at increased risk of severe attacks-Click hereProgress on early detection of Alzheimer’s disease-Click HereDried samples of saliva and fingertip blood are useful in monitoring responses to coronavirus vaccines-Click HereDietary fiber in the gut may help with skin allergies-Click HereResearchers discover mechanism linking mutations in the ‘dark matter’ of the genome to cancer-Click HereDespite dire warnings, monarch butterfly numbers are solid-Click HereImmunotherapy may get a boost-Click HereArtificial intelligence reveals a never-before described 3D structure in rotavirus spike protein-Click HereRecurring brain tumors shaped by genetic evolution and microenvironment-Click HereCompound shows promise for minimizing erratic movements in Parkinson’s patients-Click HereConsuming fruit and vegetables and exercising can make you happier-Click HereCOVID-19 slows birth rate in US, Europe-Click HereLink between ADHD and dementia across generations-Click HerePreventing the long-term effects of traumatic brain injury-Click HereStudy details robust T-cell response to mRNA COVID-19 vaccines — a more durable source of protection-Click HereArtificial color-changing material that mimics chameleon skin can detect seafood freshness-Click HereNeural implant monitors multiple brain areas at once, provides new neuroscience insights-Click HereB cell activating factor possible key to hemophilia immune tolerance-Click HereMasks not enough to stop COVID-19’s spread without distancing, study finds-Click HereAI can detect COVID-19 in the lungs like a virtual physician, new study shows-Click HerePhase 1 human trials suggest breast cancer drug is safe, effective-Click HereRe-engineered enzyme could help reverse damage from spinal cord injury and stroke-Click HereWeight between young adulthood and midlife linked to early mortality-Click HereIncreased fertility for women with Neanderthal gene, study suggests-Click HereCoronavirus testing kits to be developed using RNA imaging technology-Click HereFacial expressions don’t tell the whole story of emotion-Click HereAcid reflux drug is a surprising candidate to curb preterm birth-Click HereTreating Gulf War Illness With FDA-Approved Antiviral Drugs-Click HereHeart patch could limit muscle damage in heart attack aftermath-Click HereA nap a day keeps high blood pressure at bay-Click HereIn small groups, people follow high-performing leaders-Click HereTick tock: Commitment readiness predicts relationship success-Click HereA comprehensive ‘parts list’ of the brain built from its components, the cells-Click HereResearchers confine mature cells to turn them into stem cells-Click HereNew tissue-imaging technology could enable real-time diagnostics, map cancer progression-Click HereEverything big data claims to know about you could be wrong-Click HerePsychedelic drugs promote neural plasticity in rats and flies-Click HereEducation linked to higher risk of short-sightedness-Click HereNew 3D printer can create complex biological tissues-Click HereThe creative brain is wired differently-Click HereWomen survive crises better than men-Click HerePrecise DNA editing made easy: New enzyme to rewrite the genome-Click HereFirst Time-Lapse Footage of Cell Activity During Limb RegenerationStudy Suggests Approach to Waking Patients After Surgery

HABIT: Delaying Dementia?

0

GAINESVILLE, Fla. (Ivanhoe Newswire) — Memory loss, trouble with speech, and mood changes are some of the warning signs of dementia. While most symptoms aren’t noticeable until a person reaches his or her sixties or seventies, scientists say changes in the brain begin decades earlier. Now a specialized prevention program, started at the first signs of cognitive decline, may maximize a person’s quality of life.

When he was 20 years old Fred, Guggenheimer fell head over heels for Julie. The couple took their wedding vows four months after they met. That was 59 years ago.

Fred told Ivanhoe, “It says in sickness and in health. So, I’m going to do all I can to uphold what I promised the lord I was going to do.”

Now Fred is a caregiver for his wife who has been diagnosed with dementia.

Fred detailed, “I’ve seen her sit there and just put her hands, cause you know she’s confused. And then she just cries.”

Glenn Smith, PhD, is a Clinical Neuropsychologist in the Department of Clinical and Health Psychology at the University of Florida in Gainesville, Florida, and was part of a Mayo Clinic research team that developed habit-healthy actions to benefit independence and thinking.

“Instead of trying to find the one thing we should be doing to help them, we should be trying everything we can think of,” said Smith.

Professor Smith continues to work with seniors and their families at the University of Florida.

HABIT focuses on five strategies that can improve cognitive functioning in patients with mild impairment, starting with 60 minutes of exercise, five days a week.

“The data’s pretty solid that physical activity and exercise helps one maintain brain health,” Smith told Ivanhoe.

Researchers advocate keeping a calendar and taking notes. Some commercialized computer games are part of the program. Wellness tracking, monitoring meals, sleep and stress is one component. Also, staying socially connected.

Fred Guggenheimer believes the support is critical, especially as his wife’s dementia progresses.

Fred said, “We can’t back it up any. The best we can hope for is this will slow it down.”

In addition to HABIT, researchers in Florida are currently testing three of the five cognition strategies in what’s called the PEACEOFMND study (Physicial Exercise and Cognitive Engagement Outcomes for Mild Neurocognitive Disorder). The HABIT program has sites in Arizona, Minnesota and Florida.

Contributors to this news report include: Cyndy McGrath, Producer; Roque Correa, Editor and Videographer.

Free weekly e-mail on Medical Breakthroughs from Ivanhoe. To sign up: http://www.ivanhoe.com/ftk

 

HABIT: DELAYING DEMENTIA?
REPORT #2461

BACKGROUND: There are approximately 24 million people worldwide living with some form of dementia. This number could jump to as many as 84 million who have age-related memory loss by the year 2040. Although there are a number of forms of dementia, Alzheimer’s is the most common of the age-related memory loss diseases. Currently, more than five million Americans suffer from Alzheimer’s, and it is the seventh leading cause of death in the United States. About 13 percent of Americans over the age of 65 have Alzheimer’s and half of those over age 85 will develop Alzheimer’s, or a closely related dementia. Genetics and aging are two risk factors for dementia, and neither of these factors can be controlled. There are currently several disease-modifying therapies in development that may offer temporary slowing of disease progression or even restore cognitive function. However, it may take years before these therapies are available to the general public.

(Source: https://www.disabled-world.com/health/aging/dementia/statistics.php)

DEMENTIA CARE: Most types of dementia cannot be cured and will gradually cause more severe problems.

However, there are important exceptions, including dementia caused by vitamin deficiency and thyroid hormone deficiencies, which can be treated with supplements. Some causes can be treated surgically, such as brain tumors, excess fluid on the brain, or head injury. For types of dementia that involve degeneration of nerve and brain tissue, it is possible to prevent further damage by reducing dementia risk factors like managing high blood pressure, high cholesterol, type 1 diabetes and stopping smoking. For dementia that currently cannot be cured, some types of medicine may prevent symptoms getting worse for a period of time. These medicines are usually given to people in the early and middle stages of the disease, to try to maintain or improve their independence. Depending on the particular type of dementia, the severity of the condition, or any other issues observed by the doctor, you may be prescribed medications. However, not everyone will benefit from these drugs.

(Source: http://www.nhs.uk/Conditions/dementia-guide/Pages/dementia-treatment.aspx)

NEW RESEARCH IN DEMENTIA: New research shows a common anti-depressant, trazodone, stops brain cells from dying. The drug has already been used to treat people suffering late-stage dementia, but could be prescribed to patients at an early stage of the neurological disorder. Dr. Doug Brown, of Alzheimer’s Society, says, “We’re excited by the potential of these findings. As one of the drugs is already available as a treatment for depression, the time taken to get from the lab to the pharmacy could be dramatically reduced.” Studies show the anti-depressant works by blocking a natural defense mechanism in cells which is overactive in the brains of people with frontotemporal dementia. Experts hope it will be the first disease modifying therapy to tackle the causes of diseases like Alzheimer’s rather than simply masking the symptoms. Professor Giovanna Mallucci, of the Medical Research Council at the University of Cambridge, says, “We know that trazodone is safe to use in humans, so a clinical trial is now possible to test whether the protective effects of the drug we see on brain cells in mice with neurodegeneration, also applies to people in the early stages of Alzheimer’s and other dementias.” Results could be unveiled in as little as two to three years, which would be a very exciting first step in treating these disorders.

(Source: http://www.express.co.uk/life-style/health/793989/Dementia-news-drugs-breakthrough-experts-hunt-cure)

ADDITIONAL RESEARCH: http://www.webmd.com/alzheimers/news/20170828/women-at-risk-for-alzheimers-face-critical-window#1

 * For More Information, Contact:

 Glenn Smith, PhD                                                       Bill Levesque, PR

Dept. of Clinical and Health Psychology                    University of Florida

University of Florida                                                    William.levesque@ufl.edu

http://gesmithlab.phhp.ufl.edu/contact-us/                  325-625-0038